TRIPLE NEGATIVE BREAST CANCER

This adverse event was reported 673 times

These drugs are most commonly taken by patients reporting TRIPLE NEGATIVE BREAST CANCER:

# Drug Count
0 SACITUZUMAB GOVITECAN 229
1 PACLITAXEL 76
2 PACLITAXEL (AIBUMIN-BOUND) 61
3 PALONOSETRON HYDROCHLORIDE 55
4 DEXAMETHASONE 49
5 DEXAMETHASONE 1.5 MG 49
6 ATEZOLIZUMAB 45
7 PEGFILGRASTIM 43
8 DOCETAXEL 37
9 DOCETAXEL ANHYDROUS 37
See all common drugs associated with TRIPLE NEGATIVE BREAST CANCER

TRIPLE NEGATIVE BREAST CANCER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SACITUZUMAB GOVITECAN 229 0.0474
1 PALONOSETRON HYDROCHLORIDE 55 0.0102
2 SONIDEGIB 17 0.0101
3 PEGFILGRASTIM 43 0.0036
4 NALDEMEDINE 4 0.0024
5 PHENOBARBITAL SODIUM 1 0.0024
6 DEXAMETHASONE SODIUM PHOSPHATE 24 0.0023
7 GARADACIMAB 1 0.0013
8 ATEZOLIZUMAB 45 0.0011
9 GRANISETRON HYDROCHLORIDE 11 0.0010
See all drugs enriched for association with TRIPLE NEGATIVE BREAST CANCER